{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T17:03:39Z","timestamp":1773248619880,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,3,6]],"date-time":"2014-03-06T00:00:00Z","timestamp":1394064000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1038\/hr.2014.49","type":"journal-article","created":{"date-parts":[[2014,3,6]],"date-time":"2014-03-06T07:01:54Z","timestamp":1394089314000},"page":"616-620","source":"Crossref","is-referenced-by-count":42,"title":["Role of angiotensin-converting enzyme 2\/angiotensin-(1\u20137)\/Mas axis in the hypotensive effect of azilsartan"],"prefix":"10.1038","volume":"37","author":[{"given":"Jun","family":"Iwanami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Mogi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kana","family":"Tsukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotomo","family":"Nakaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kousei","family":"Ohshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Chisaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Yu","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harumi","family":"Kanno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Juan","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatsugu","family":"Horiuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,6]]},"reference":[{"key":"BFhr201449_CR1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1161\/HYPERTENSIONAHA.109.140145","volume":"55","author":"AJ Ferreira","year":"2010","unstructured":"Ferreira AJ, Santos RA, Bradford CN, Mecca AP, Sumners C, Katovich MJ, Raizada MK . Therapeutic implications of the vasoprotective axis of the renin-angiotensin system in cardiovascular diseases. Hypertension 2010; 55: 207\u2013213.","journal-title":"Hypertension"},{"key":"BFhr201449_CR2","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1042\/CS20120461","volume":"124","author":"DG Passos-Silva","year":"2013","unstructured":"Passos-Silva DG, Verano-Braga T, Santos RA . Angiotensin-(1\u20137): beyond the cardio-renal actions. Clin Sci (Lond) 2013; 124: 443\u2013456.","journal-title":"Clin Sci (Lond)"},{"key":"BFhr201449_CR3","doi-asserted-by":"publisher","first-page":"H684","DOI":"10.1152\/ajpheart.00632.2005","volume":"290","author":"IF Benter","year":"2006","unstructured":"Benter IF, Yousif MH, Anim JT, Cojocel C, Diz DI . Angiotensin-(1\u20137) prevents development of severe hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME. Am J Physiol Heart Circ Physiol 2006; 290: H684\u2013H691.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFhr201449_CR4","doi-asserted-by":"publisher","first-page":"F272","DOI":"10.1152\/ajprenal.00278.2010","volume":"300","author":"JF Giani","year":"2011","unstructured":"Giani JF, Mu\u00f1oz MC, Pons RA, Cao G, Toblli JE, Turyn D, Dominici FP . Angiotensin-(1\u20137) reduces proteinuria and diminishes structural damage in renal tissue of stroke-prone spontaneously hypertensive rats. Am J Physiol Renal Physiol 2011; 300: F272\u2013F282.","journal-title":"Am J Physiol Renal Physiol"},{"key":"BFhr201449_CR5","doi-asserted-by":"crossref","first-page":"11617","DOI":"10.1016\/S0021-9258(19)50246-0","volume":"268","author":"A Fukamizu","year":"1993","unstructured":"Fukamizu A, Sugimura K, Takimoto E, Sugiyama F, Seo MS, Takahashi S, Hatae T, Kajiwara N, Yagami K, Murakami K . Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes. J Biol Chem 1993; 268: 11617\u201311621.","journal-title":"J Biol Chem"},{"key":"BFhr201449_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/nrneph.2012.249","volume":"9","author":"B Sev\u00e1 Pess\u00f4a","year":"2013","unstructured":"Sev\u00e1 Pess\u00f4a B, van der Lubbe N, Verdonk K, Roks AJ, Hoorn EJ, Danser AH . Key developments in renin-angiotensin-aldosterone system inhibition. Nat Rev Nephrol 2013; 9: 26\u201336.","journal-title":"Nat Rev Nephrol"},{"key":"BFhr201449_CR7","doi-asserted-by":"publisher","first-page":"H1013","DOI":"10.1152\/ajpheart.00068.2005","volume":"289","author":"M Igase","year":"2005","unstructured":"Igase M, Strawn WB, Gallagher PE, Geary RL, Ferrario CM . Angiotensin II AT1 receptors regulate ACE2 and angiotensin-(1\u20137) expression in the aorta of spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 2005; 289: H1013\u2013H1019.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFhr201449_CR8","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.2353\/ajpath.2008.070762","volume":"172","author":"V Koka","year":"2008","unstructured":"Koka V, Huang XR, Chung AC, Wang W, Truong LD, Lan HY . Angiotensin II up-regulates angiotensin I-converting enzyme (ACE), but down-regulates ACE2 via the AT1-ERK\/p38 MAP kinase pathway. Am J Pathol 2008; 172: 1174\u20131183.","journal-title":"Am J Pathol"},{"key":"BFhr201449_CR9","doi-asserted-by":"publisher","first-page":"C1169","DOI":"10.1152\/ajpcell.00145.2008","volume":"295","author":"PE Gallagher","year":"2008","unstructured":"Gallagher PE, Ferrario CM, Tallant EA . MAP kinase\/phosphatase pathway mediates the regulation of ACE2 by angiotensin peptides. Am J Physiol Cell Physiol 2008; 295: C1169\u2013C1174.","journal-title":"Am J Physiol Cell Physiol"},{"key":"BFhr201449_CR10","doi-asserted-by":"publisher","first-page":"H2373","DOI":"10.1152\/ajpheart.00426.2008","volume":"295","author":"PE Gallagher","year":"2008","unstructured":"Gallagher PE, Ferrario CM, Tallant EA . Regulation of ACE2 in cardiac myocytes and fibroblasts. Am J Physiol Heart Circ Physiol 2008; 295: H2373\u2013H2379.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFhr201449_CR11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1161\/HYPERTENSIONAHA.112.191452","volume":"60","author":"M Iwai","year":"2012","unstructured":"Iwai M, Nakaoka H, Senba I, Kanno H, Moritani T, Horiuchi M . Possible involvement of angiotensin-converting enzyme 2 and Mas activation in inhibitory effects of angiotensin II Type 1 receptor blockade on vascular remodeling. Hypertension 2012; 60: 137\u2013144.","journal-title":"Hypertension"},{"key":"BFhr201449_CR12","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1124\/jpet.110.176636","volume":"336","author":"M Ojima","year":"2011","unstructured":"Ojima M, Igata H, Tanaka M, Sakamoto H, Kuroita T, Kohara Y, Kubo K, Fuse H, Imura Y, Kusumoto K, Nagaya H . In vitro antagonistic properties of a new angiotensin type 1 receptor blocker, azilsartan, in receptor binding and function studies. J Pharmacol Exp Ther 2011; 336: 801\u2013808.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFhr201449_CR13","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/jhh.2013.6","volume":"27","author":"G B\u00f6nner","year":"2013","unstructured":"B\u00f6nner G, Bakris GL, Sica D, Weber MA, White WB, Perez A, Cao C, Handley A, Kupfer S . Antihypertensive efficacy of the angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril. J Hum Hypertens 2013; 27: 479\u2013486.","journal-title":"J Hum Hypertens"},{"key":"BFhr201449_CR14","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1161\/HYPERTENSIONAHA.110.163402","volume":"57","author":"WB White","year":"2011","unstructured":"White WB, Weber MA, Sica D, Bakris GL, Perez A, Cao C, Kupfer S . Effects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 hypertension. Hypertension 2011; 57: 413\u2013420.","journal-title":"Hypertension"},{"key":"BFhr201449_CR15","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1152\/jappl.2000.88.5.1537","volume":"88","author":"PA Mills","year":"2000","unstructured":"Mills PA, Huetteman DA, Brockway BP, Zwiers LM, Gelsema AJ, Schwartz RS, Kramer K . A new method for measurement of blood pressure, heart rate, and activity in the mouse by radiotelemetry. J Appl Physiol 2000; 88: 1537\u20131544.","journal-title":"J Appl Physiol"},{"key":"BFhr201449_CR16","doi-asserted-by":"publisher","first-page":"17985","DOI":"10.1073\/pnas.0605545103","volume":"103","author":"SD Crowley","year":"2006","unstructured":"Crowley SD, Gurley SB, Herrera MJ, Ruiz P, Griffiths R, Kumar AP, Kim HS, Smithies O, Le TH, Coffman TM . Angiotensin II causes hypertension and cardiac hypertrophy through its receptor in the kidney. Proc Natl Acad Sci USA 2006; 103: 17985\u201317990.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFhr201449_CR17","doi-asserted-by":"publisher","first-page":"F1124","DOI":"10.1152\/ajprenal.00305.2011","volume":"301","author":"SD Crowley","year":"2011","unstructured":"Crowley SD, Zhang J, Herrera M, Griffiths R, Ruiz P, Coffman TM . Role of AT1 receptor-mediated salt retention in angiotensin II-dependent hypertension. Am J Physiol Renal Physiol 2011; 301: F1124\u2013F1130.","journal-title":"Am J Physiol Renal Physiol"},{"key":"BFhr201449_CR18","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1074\/jbc.M111.298919","volume":"287","author":"M Mamenko","year":"2012","unstructured":"Mamenko M, Zaika O, Ilatovskaya DV, Staruschenko A, Pochynyuk O . Angiotensin II increases activity of the epithelial Na+ channel (ENaC) in distal nephron additively to aldosterone. J Biol Chem 2012; 287: 660\u2013671.","journal-title":"J Biol Chem"},{"key":"BFhr201449_CR19","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1097\/HJH.0b013e32832f0d06","volume":"27","author":"M B\u00fcrgelov\u00e1","year":"2009","unstructured":"B\u00fcrgelov\u00e1 M, Vanourkov\u00e1 Z, Thumov\u00e1 M, Dvor\u00e1k P, Opocensk\u00fd M, Kramer HJ, Zel\u00edzko M, Mal\u00fd J, Bader M, Cervenka L . Impairment of the angiotensin-converting enzyme 2-angiotensin-(1\u20137)-Mas axis contributes to the acceleration of two-kidney, one-clip Goldblatt hypertension. J Hypertens 2009; 27: 1988\u20132000.","journal-title":"J Hypertens"},{"key":"BFhr201449_CR20","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/0092-8674(94)90250-X","volume":"79","author":"RA Shimkets","year":"1994","unstructured":"Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C, Hansson JH, Schambelan M, Gill JR, Ulick S, Milora RV, Findling JW, Canessa CM, Rossier BC, Lifton RP . Liddle\u2019s syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell 1994; 79: 407\u2013414.","journal-title":"Cell"},{"key":"BFhr201449_CR21","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/ng0396-248","volume":"12","author":"SS Chang","year":"1996","unstructured":"Chang SS, Grunder S, Hanukoglu A, Rosler A, Mathew PM, Hanukoglu I, Schild L, Lu Y, Shimkets RA, Nelson-Williams C, Rossier BC, Lifton RP . Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1. Nat Genet 1996; 12: 248\u2013253.","journal-title":"Nat Genet"},{"key":"BFhr201449_CR22","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1161\/01.HYP.0000124667.34652.1a","volume":"43","author":"Y Ishiyama","year":"2004","unstructured":"Ishiyama Y, Gallagher PE, Averill DB, Tallant EA, Brosnihan KB, Ferrario CM . Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors. Hypertension 2004; 43: 970\u2013976.","journal-title":"Hypertension"},{"key":"BFhr201449_CR23","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1042\/CS20120162","volume":"123","author":"LJ Burchill","year":"2012","unstructured":"Burchill LJ, Velkoska E, Dean RG, Griggs K, Patel SK, Burrell LM . Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions. Clin Sci (Lond) 2012; 123: 649\u2013658.","journal-title":"Clin Sci (Lond)"},{"key":"BFhr201449_CR24","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","volume":"111","author":"CM Ferrario","year":"2005","unstructured":"Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosnihan KB, Tallant EA, Diz DI, Gallagher PE . Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation 2005; 111: 2605\u20132610.","journal-title":"Circulation"},{"key":"BFhr201449_CR25","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jash.2013.03.002","volume":"7","author":"T Moritani","year":"2013","unstructured":"Moritani T, Iwai M, Kanno H, Nakaoka H, Iwanami J, Higaki T, Ishii E, Horiuchi M . ACE2 deficiency induced perivascular fibrosis and cardiac hypertrophy during postnatal development in mice. J Am Soc Hypertens 2013; 7: 259\u2013266.","journal-title":"J Am Soc Hypertens"},{"key":"BFhr201449_CR26","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1097\/HJH.0b013e32834bbb4d","volume":"29","author":"S Inaba","year":"2011","unstructured":"Inaba S, Iwai M, Furuno M, Kanno H, Senba I, Okayama H, Mogi M, Higaki J, Horiuchi M . Role of angiotensin-converting enzyme 2 in cardiac hypertrophy induced by nitric oxide synthase inhibition. J Hypertens 2011; 29: 2236\u20132245.","journal-title":"J Hypertens"},{"key":"BFhr201449_CR27","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/hr.2009.231","volume":"33","author":"A Shiota","year":"2010","unstructured":"Shiota A, Yamamoto K, Ohishi M, Tatara Y, Ohnishi M, Maekawa Y, Iwamoto Y, Takeda M, Rakugi H . Loss of ACE2 accelerates time-dependent glomerular and tubulointerstitial damage in streptozotocin-induced diabetic mice. Hypertens Res 2010; 33: 298\u2013307.","journal-title":"Hypertens Res"},{"key":"BFhr201449_CR28","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/ajh\/hps090","volume":"26","author":"J Varagic","year":"2013","unstructured":"Varagic J, Ahmad S, VonCannon JL, Moniwa N, Brosnihan KB, Wysocki J, Batlle D, Ferrario CM . Predominance of AT(1) blockade over mas-mediated angiotensin-(1\u20137) mechanisms in the regulation of blood pressure and renin-angiotensin system in mRen2.Lewis rats. Am J Hypertens 2013; 26: 583\u2013590.","journal-title":"Am J Hypertens"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/hr201449.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr201449","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr201449.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:14:19Z","timestamp":1684430059000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/hr201449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,6]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["BFhr201449"],"URL":"https:\/\/doi.org\/10.1038\/hr.2014.49","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,6]]}}}